Clinical trial
The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection
NCT04326452 is registered in ClinicalTrials.gov with TMC HealthCare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection
- Lead sponsor
- TMC HealthCare
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 27, 2020
- Completion date
- March 27, 2021
- Enrollment
- 10 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus infection